Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inno4Vac influenza human challenge dose-escalation study
NL-OMON61391Recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Aug 2026
- Countries
- 1
01
Overview
Open-label trial in influenza (3 cohorts), sponsored by Centre for Human Drug Research. Primary endpoints: Establishment of influenza CHIM, Dose finding for influenza disease induction and 1 more. Started Aug 2026; status: recruiting.
02
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON61391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61391.